SIGNAL TRANSDUCTION PATHWAYS LINKING THE ACTIVATION OF ALVEOLAR MACROPHAGES WITH THE RECRUITMENT OF NEUTROPHILS TO LUNGS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

REFERENCES

• Lopez A D, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757
   PubMed Web of Science ®Google Scholar
• Halbert R J, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523–532
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9: 458–465
   PubMed Web of Science ®Google Scholar
• http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=996
   Google Scholar
• David M, et al. Smoking and Tobacco Control. Monograph 8. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. 1–11, NIH Publication. 1997; No. 97–4213
   Google Scholar
• Rabe K F, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176: 532–555
   PubMed Web of Science ®Google Scholar
• Retamales I, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469–473
   PubMed Web of Science ®Google Scholar
• Lofdahl J M, et al. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin Exp Immunol 2006; 145: 428–437
   PubMed Web of Science ®Google Scholar
• Ofulue A F, et al. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol 1999; 277: L97–L105
   PubMed Web of Science ®Google Scholar
• Barnes P J, et al. Alveolar macrophages as orchestrators of COPD. COPD 2004; 1: 59–70
   PubMedGoogle Scholar
• Domagala-Kulawik J, et al. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2006; 57(Suppl 4)75–84
   PubMedGoogle Scholar
• Di Stefano A, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158: 1277–1285
   PubMed Web of Science ®Google Scholar
• Tetley T D, et al. Macrophages and the pathogenesis of COPD. Chest 2002; 121(5 Suppl)156S–159S
   PubMed Web of Science ®Google Scholar
• Barnes P J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515–548
   PubMed Web of Science ®Google Scholar
• Pons A R, et al. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 2005; 25: 647–652
   PubMed Web of Science ®Google Scholar
• Bardelli C, et al. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 2005; 145: 385–396
   PubMed Web of Science ®Google Scholar
• Gunella G, et al. Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway. Br J Pharmacol 2006; 148: 478–489
   PubMed Web of Science ®Google Scholar
• Marian E, et al. Up-regulated membrane and nuclear leukotriene B4 receptors in COPD. Chest 2006; 129: 1523–1530
   PubMed Web of Science ®Google Scholar
• Hodge S, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in COPD. Am J Respir Cell Mol Biol 2007; 37: 748–755
   PubMed Web of Science ®Google Scholar
• Heguy A, et al. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 2006; 84: 318–328
   PubMed Web of Science ®Google Scholar
• Higashimoto Y, et al. Effect of chronic tobacco smoke exposure on the function of alveolar macrophages in mice. Respiration 1994; 61: 23–27
   PubMed Web of Science ®Google Scholar
• Kirkham P A, et al. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun 2004; 318: 32–37
   PubMed Web of Science ®Google Scholar
• Woodruff P G, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005; 172: 1383–1392
   PubMed Web of Science ®Google Scholar
• Reutershan J, et al. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 289: L807–L815
   PubMed Web of Science ®Google Scholar
• Balbi B. COPD: is chemotaxis the key?. Chest 2003; 123: 983–986
   PubMed Web of Science ®Google Scholar
• Hoffmann E, et al. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002; 72: 847–855
   PubMed Web of Science ®Google Scholar
• Strieter R M, et al. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax 1993; 48: 765–769
   PubMed Web of Science ®Google Scholar
• Keatings V M, et al. Differences in interleukin-8 and tumour necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530–534
   PubMed Web of Science ®Google Scholar
• Beeh K M, et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003; 123: 1240–1247
   PubMed Web of Science ®Google Scholar
• Richman-Eisenstat J B, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264: L413–L418, (4 Pt 1)
   PubMedGoogle Scholar
• Chang Y H, et al. Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation. Exp Cell Res 2002; 278: 166–174
   PubMed Web of Science ®Google Scholar
• Barnes P J, et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–1071
   PubMed Web of Science ®Google Scholar
• Hayden M S, et al. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195–2224
   PubMed Web of Science ®Google Scholar
• Caramori G, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 2003; 58: 348–351
   PubMed Web of Science ®Google Scholar
• Karimi K, et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 2006; 7: 66
   PubMed Web of Science ®Google Scholar
• Mechta-Grigoriou F, et al. The mammalian Jun proteins: redundancy and specificity. Oncogene 2001; 20: 2378–2389
   PubMed Web of Science ®Google Scholar
• Ng K W, et al. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J 1997; 16: 2072–2085
   PubMed Web of Science ®Google Scholar
• Wodrich W, et al. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis 1993; 14: 1121–1124
   PubMed Web of Science ®Google Scholar
• Hirama N, et al. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 2007; 12: 191–201
   PubMed Web of Science ®Google Scholar
• Walters M J, et al. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol 2005; 68: 1343–1353
   PubMed Web of Science ®Google Scholar
• Culpitt S V, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 24–31
   PubMed Web of Science ®Google Scholar
• Ohta T, et al. Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med 1998; 92: 922–927
   PubMed Web of Science ®Google Scholar
• Dubar V, et al. In vitro acute effects of tobacco smoke on tumour necrosis factor alpha and interleukin-6 production by alveolar macrophages. Exp Lung Res 1993; 19: 345–359
   PubMed Web of Science ®Google Scholar
• Zhang G, et al. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13–19
   PubMed Web of Science ®Google Scholar
• Maes T, et al. Murine TLR-4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 2006; 141: 354–368
   PubMed Web of Science ®Google Scholar
• Dong W, et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4. J Biol Chem 2006; 281: 26029–26040
   PubMed Web of Science ®Google Scholar
• Shim J H, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19: 2668–2681
   PubMed Web of Science ®Google Scholar
• Irie T, et al. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages. FEBS Lett 2000; 467: 160–164
   PubMed Web of Science ®Google Scholar
• Horng T, et al. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835–841
   PubMed Web of Science ®Google Scholar
• Toshchakov V, et al. TLR-4, but not TLR-2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392–398
   PubMed Web of Science ®Google Scholar
• Yamamoto M, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4: 1144–1150
   PubMed Web of Science ®Google Scholar
• Yamamoto M, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640–643
   PubMed Web of Science ®Google Scholar
• Anto R J, et al. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002; 23: 1511–1518
   PubMed Web of Science ®Google Scholar
• Smith S J, et al. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 2006; 149: 393–404
   PubMed Web of Science ®Google Scholar
• Yang S R, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291: L46–L57
   PubMed Web of Science ®Google Scholar
• Ito K, et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15: 1110–1112
   PubMedGoogle Scholar
• Ito K, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006; 203: 7–13
   PubMed Web of Science ®Google Scholar
• Ito K, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352: 1967–1976
   PubMed Web of Science ®Google Scholar
• Adcock I M, et al. Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest Dis 2000; 55: 256–266
   PubMedGoogle Scholar
• Ito K. Impact of post-translational modifications of proteins on the inflammatory process. Biochem Soc Trans 2007; 35: 281–283
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 2007; 25: 543–557
   PubMed Web of Science ®Google Scholar
• Borra M T, et al. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 2004; 43: 9877–9887
   PubMed Web of Science ®Google Scholar
• Yang S R, et al. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292: L567–L576
   PubMed Web of Science ®Google Scholar
• Facchinetti F, et al. {alpha},{beta}-Unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol 2007; 37: 617–623
   PubMed Web of Science ®Google Scholar
• Birrell M A, et al. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2007; 214: 27–37
   Web of Science ®Google Scholar
• Martin T R. Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000; 23: 128–132
   PubMed Web of Science ®Google Scholar
• Hasday J D, et al. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829–835
   PubMed Web of Science ®Google Scholar
• Brass D M, et al. Subchronic endotoxin inhalation causes persistent airway disease. Am J Physiol Lung Cell Mol Physiol 2003; 285: L755–L761
   PubMed Web of Science ®Google Scholar
• George C L, et al. Endotoxin responsiveness and subchronic grain dust-induced airway disease. Am J Physiol Lung Cell Mol Physiol 2001; 280: L203–L213
   PubMed Web of Science ®Google Scholar
• Mochida-Nishimura K, et al. Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med 2001; 7: 177–185
   PubMed Web of Science ®Google Scholar
• Hollingsworth J W, et al. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 2004; 170: 126–132
   PubMed Web of Science ®Google Scholar
• Brass D M, et al. CD14 is an essential mediator of LPS induced airway disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L77–L83
   PubMed Web of Science ®Google Scholar
• Hollingsworth J W, et al. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 2005; 171: 806–813
   PubMedGoogle Scholar
• Blackwell T S, et al. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kappa B activation. Am J Respir Cell Mol Biol 1994; 11: 464–472
   PubMed Web of Science ®Google Scholar
• Carter A B, et al. Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 1998; 18: 384–391
   PubMed Web of Science ®Google Scholar
• Koch A, et al. Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J 2004; 23: 805–812
   PubMed Web of Science ®Google Scholar
• Kim H J, et al. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 2006; 225: 36–47
   PubMed Web of Science ®Google Scholar
• Papavlassopoulos M, et al. MaxiK blockade selectively inhibits the lipopolysaccharide-induced I kappa B-α /NF-kappa B signaling pathway in macrophages. J Immunol 2006; 177: 4086–4093
   PubMed Web of Science ®Google Scholar
• Kobayashi K, et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191–202
   PubMed Web of Science ®Google Scholar
• Zhang G, et al. Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 2002; 277: 7059–7065
   PubMed Web of Science ®Google Scholar
• O'Reilly S M, et al. Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. Biochem Biophys Res Commun 2003; 303: 586–593
   PubMed Web of Science ®Google Scholar
• Liang J, et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 2007; 178: 2469–2475
   PubMed Web of Science ®Google Scholar
• Martin T R, et al. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106–111
   PubMed Web of Science ®Google Scholar
• Crooks S W, et al. Leukotriene B4. Int J Biochem Cell Biol 1998; 30: 173–178
   PubMed Web of Science ®Google Scholar
• Crooks S W, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J 2000; 15: 274–280
   PubMed Web of Science ®Google Scholar
• Martin T R, et al. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest 1987; 80: 1114–1124
   PubMed Web of Science ®Google Scholar
• Profita M, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005; 60: 1361–1369
   PubMed Web of Science ®Google Scholar
• Takahashi H, et al. Structure of the human neutrophil elastase gene. J Biol Chem 1988; 263: 14739–14747
   PubMed Web of Science ®Google Scholar
• Shapiro S D, et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003; 163: 2329–2335
   PubMed Web of Science ®Google Scholar
• Hubbard R C, et al. Neutrophil accumulation in the lung in α 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991; 88: 891–897
   PubMed Web of Science ®Google Scholar
• Janoff A, et al. NHLBI workshop summary. Effects of tobacco smoke components on cellular and biochemical processes in the lung. Am Rev Respir Dis 1987; 136: 1058–1064
   PubMed Web of Science ®Google Scholar
• Hubbard R C, et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80: 1289–1295
   PubMed Web of Science ®Google Scholar
• Ogushi F, et al. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J Clin Invest 1991; 87: 1060–1065
   PubMed Web of Science ®Google Scholar
• Ganz T, et al. Defensins. Eur J Haematol 1990; 44: 1–8
   PubMed Web of Science ®Google Scholar
• Van Wetering S, et al. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol 1997; 62: 217–226
   PubMed Web of Science ®Google Scholar
• Spencer L T, et al. Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004; 286: L514–L520
   PubMed Web of Science ®Google Scholar
• Coffey M J, et al. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol 2000; 165: 3592–3598
   PubMed Web of Science ®Google Scholar
• Robbins R A, et al. Modulation of alveolar macrophage leukotriene B4 released by complement component C5. J Lab Clin Med 1990; 115: 497–503
   PubMedGoogle Scholar
• Profita M, et al. 15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis. Am J Physiol Cell Physiol 2000; 279: C1249–C1258
   PubMed Web of Science ®Google Scholar
• Petrich K, et al. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid:structure-activity relationship and mechanism of action. Biochem J 1996; 314: 911–916
   PubMed Web of Science ®Google Scholar
• Takata S, et al. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 1994; 93: 499–508
   PubMed Web of Science ®Google Scholar
• Laviolette M, et al. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest 1986; 77: 54–60
   PubMed Web of Science ®Google Scholar
• Wieslander E, et al. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors. Eur J Respir Dis 1987; 71: 263–272
   PubMedGoogle Scholar
• Tardif J, et al. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke. Am J Respir Cell Mol Biol 1990; 2: 155–161
   PubMed Web of Science ®Google Scholar
• Balter M S, et al. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers. J Lab Clin Med 1989; 114: 662–673
   PubMedGoogle Scholar
• Mobley A, et al. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking. Biochim Biophys Acta 1987; 918: 115–119
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, et al. Effects of smoking on the synthesis of leukotriene B4 by rat alveolar macrophages. Respiration 1989; 56: 198–203
   PubMed Web of Science ®Google Scholar
• Mao J T, et al. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res 2004; 10: 6872–6878
   PubMed Web of Science ®Google Scholar
• Droemann D, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005; 6: 68
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, et al. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006; 7: 125
   PubMed Web of Science ®Google Scholar
• Kriegler M, et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 45–53
   PubMed Web of Science ®Google Scholar
• Lundblad L K, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005; 171: 1363–1370
   PubMed Web of Science ®Google Scholar
• Wilson A G, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195–3199
   PubMed Web of Science ®Google Scholar
• Huang S L, et al. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436–1439
   PubMed Web of Science ®Google Scholar
• Sakao S, et al. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 420–422
   PubMed Web of Science ®Google Scholar
• Jiang L, et al. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J (Engl) 2005; 118: 541–547
   PubMed Web of Science ®Google Scholar
• Chierakul N, et al. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 2005; 10: 36–39
   PubMed Web of Science ®Google Scholar
• Kucukaycan M, et al. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 2002; 3: 29
   PubMedGoogle Scholar
• McCrea K A, et al. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150: 696–703
   PubMed Web of Science ®Google Scholar
• Dandrea T, et al. Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and non-smokers by NO2. Hum Exp Toxicol 1997; 16: 577–588
   PubMed Web of Science ®Google Scholar
• Morimoto Y, et al. Synergistic effects of mineral fibres and cigarette smoke on the production of tumour necrosis factor by alveolar macrophages of rats. Br J Ind Med 1993; 50: 955–960
   PubMedGoogle Scholar
• Lim S, et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000; 162: 1355–1360, (4 Pt 1)
   PubMed Web of Science ®Google Scholar
• Takabatake N, et al. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 1215–1220
   PubMed Web of Science ®Google Scholar
• Yu M, et al. Short-term exposure to aged and diluted sidestream cigarette smoke enhances ozone-induced lung injury in B6C3F1 mice. Toxicol Sci 2002; 65: 99–106
   PubMed Web of Science ®Google Scholar
• Demirjian L, et al. Acute effect of cigarette smoke on TNF-alpha release by macrophages mediated through the erk1/2 pathway. Biochim Biophys Acta 2006; 1762: 592–597
   PubMed Web of Science ®Google Scholar
• Churg A, et al. {alpha}-1-Antitrypsin suppresses TNF{alpha} and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 2007; 37: 144–151
   PubMed Web of Science ®Google Scholar
• Cosio B G, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200: 689–695
   PubMed Web of Science ®Google Scholar
• Vayssier M, et al. Tobacco smoke induces coordinate activation of HSF and inhibition of NFkappaB in human monocytes: effects on TNFalpha release. Biochem Biophys Res Commun 1998; 252: 249–256
   PubMed Web of Science ®Google Scholar
• Kafoury R M, et al. Diesel exhaust particles induce the over expression of tumor necrosis factor-alpha (TNF-alpha) gene in alveolar macrophages and failed to induce apoptosis through activation of nuclear factor-kappaB (NF-kappaB). Int J Environ Res Public Health 2005; 2: 107–113
   PubMedGoogle Scholar
• Määttä J, et al. Comparison of hardwood and softwood dust-induced expression of cytokines and chemokines in mouse macrophage RAW 264.7 cells. Toxicology 2006; 218: 13–21
   PubMed Web of Science ®Google Scholar
• Maatta J, et al. Characterization of oak and birch dust-induced expression of cytokines and chemokines in mouse macrophage RAW 264.7 cells. Toxicology 2005; 215: 25–36
   PubMed Web of Science ®Google Scholar
• Honda Y, et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996; 109: 1006–1009
   PubMed Web of Science ®Google Scholar
• Alcorn J F, et al. Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am Physiol Lung Cell Mol Physiol 2004; 286: L129–L136
   PubMed Web of Science ®Google Scholar
• Han J, et al. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J Immunol 1991; 146: 1843–1848
   PubMed Web of Science ®Google Scholar
• Jeong J Y, et al. Tosylphenylalanine chloromethyl ketone inhibits TNF-alpha mRNA synthesis in the presence of activated NF-kappa B in RAW 264.7 macrophages. Immunology 1997; 92: 267–273
   PubMed Web of Science ®Google Scholar
• Lo C J, et al. Macrophage TNF mRNA expression is modulated by protease inhibitors. J Surg Res 1997; 69: 408–412
   PubMed Web of Science ®Google Scholar
• Geppert T D, et al. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med 1994; 1: 93–103
   PubMed Web of Science ®Google Scholar
• Swantek J L, et al. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol 1997; 17: 6274–6282
   PubMed Web of Science ®Google Scholar
• Berclaz P Y, et al. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. Am J Respir Cell Mol Biol 2007; 36: 114–121
   PubMedGoogle Scholar
• Laza-Stanca V, et al. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 2006; 80: 8248–8258
   PubMed Web of Science ®Google Scholar
• Castro P, et al. Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol 2004; 498: 279–286
   PubMed Web of Science ®Google Scholar
• Churg A, et al. Tumour necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004; 170: 492–498
   PubMed Web of Science ®Google Scholar
• Churg A, et al. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002; 166: 849–854
   PubMed Web of Science ®Google Scholar
• D'hulst A L, et al. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006; 28: 102–112
   PubMed Web of Science ®Google Scholar
• Churg A, et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumour necrosis factor-alpha release. Am J Respir Crit Care Med 2003; 167: 1083–1089
   PubMed Web of Science ®Google Scholar
• Ishii Y, et al. Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure. Toxicol Appl Pharmacol 1997; 147: 214–223
   PubMed Web of Science ®Google Scholar
• Rolfe M W, et al. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 1991; 5: 493–501
   PubMed Web of Science ®Google Scholar
• Standiford T J, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. J Clin Invest 1990; 86: 1945–1953
   PubMed Web of Science ®Google Scholar
• Li Y, et al. TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 647–650
   PubMedGoogle Scholar
• Chung K F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001; 50s–59s, Suppl 34
   Google Scholar
• Garofalo R, et al. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 1996; 157: 2506–113
   PubMed Web of Science ®Google Scholar
• Yang G H, et al. Effects of interleukin-1 beta on DNA synthesis in rat alveolar type II cells in primary culture. Respirology 1999; 4: 139–145
   PubMedGoogle Scholar
• Lappalainen U, et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32: 311–318
   PubMed Web of Science ®Google Scholar
• Lucey E C, et al. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest 2002; 82: 79–85
   PubMed Web of Science ®Google Scholar
• Russell R E, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26: 602–609
   PubMed Web of Science ®Google Scholar
• Wesselius L J, et al. Rapid lung cytokine accumulation and neutrophil recruitment after lipopolysaccharide inhalation by cigarette smokers and nonsmokers. J Lab Clin Med 1997; 129: 106–114
   PubMedGoogle Scholar
• Nagai S, et al. Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988; 94: 694–700
   PubMed Web of Science ®Google Scholar
• Rupp J, et al. Imbalanced secretion of IL-1beta and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients. Eur Respir J 2003; 22: 274–279
   PubMed Web of Science ®Google Scholar
• Joos L, et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 2001; 56: 863–866
   PubMed Web of Science ®Google Scholar
• Brown G P, et al. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol 1989; 256: C260–C264
   PubMed Web of Science ®Google Scholar
• Castranova V, et al. Effect of exposure to diesel exhaust particles on the susceptibility of the lung to infection. Environ Health Perspect 2001; 109(Suppl 4)609–612
   PubMed Web of Science ®Google Scholar
• Yang H M, et al. Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: evidence of DEP suppression of macrophage activity. J Toxicol Environ Health A 1999; 58: 261–278
   PubMed Web of Science ®Google Scholar
• O'Brien-Ladner A R, et al. Iron is a regulatory component of human IL-1beta production. Support for regional variability in the lung. Am J Respir Cell Mol Biol 2000; 23: 112–119
   PubMed Web of Science ®Google Scholar
• O'Brien-Ladner A R, et al. Differential regulation of human alveolar macrophage-derived interleukin-1beta and tumor necrosis factor-alpha by iron. J Lab Clin Med 1998; 132: 497–506
   PubMed Web of Science ®Google Scholar
• Li Y Q, et al. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms. Acta Pharmacol Sin 2006; 27: 339–346
   PubMed Web of Science ®Google Scholar
• Strieter R M, et al. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 1994; 42: 640–651
   PubMed Web of Science ®Google Scholar
• Becker S, et al. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am J Physiol 1994; 266: L278–L286, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Traves S L, et al. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002; 57: 590–595
   PubMed Web of Science ®Google Scholar
• Ko F W, et al. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir Med 2006; 100: 630–638
   PubMed Web of Science ®Google Scholar
• Chen H W, et al. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 2006; 20: 2393–2395
   PubMed Web of Science ®Google Scholar
• Carr M W, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994; 91: 3652–3656
   PubMed Web of Science ®Google Scholar
• de Boer W I, et al. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000; 190: 619–626
   PubMed Web of Science ®Google Scholar
• Kirkham P A, et al. Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 2003; 35: 697–710
   PubMed Web of Science ®Google Scholar
• Hautamaki R D, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002–2004
   PubMed Web of Science ®Google Scholar
• Capelli A, et al. Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J 1999; 14: 160–165
   PubMed Web of Science ®Google Scholar
• Bracke K R, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006; 177: 4350–4359
   PubMed Web of Science ®Google Scholar
• Aldonyte R, et al. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003; 4: 11
   PubMed Web of Science ®Google Scholar